why is there a shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Hims? Hers? It's Novo Nordisk's

Similar findings were replicated in the study population with T2D when comparing semaglutide with non-GLP-1RA anti-diabetes medications for incident CUD (HR: 0.40, 95% CI: 0.290.56) and recurrent CUD (HR: 0.66, 95% CI: 0.421.03)

Nicotine, like alcohol, activates the brains reward systems, leading to the release of dopamine, which reinforces the habit of smoking

When early dosing creates actual risk Early dosing moves from "safe flexibility" to "risky" in these situations: You're already experiencing significant side effects

ICER looks good over long term Budget Impact still very high today So the key question is: Are GLP-1s cost-effective or truly affordable at scale